3rd Circ. Says Suit Over HIV Drug IP Belongs In France

Law360, New York (October 13, 2010, 3:11 PM EDT) -- A federal appeals court has ruled that France is the proper forum for a suit by Eurofins Pharma U.S. Holdings Inc. alleging that BioAlliance Pharma SA failed to disclose that its HIV drug-testing technology was being accused of patent infringement when it entered a contract to transfer the technology to Eurofins.

The U.S. Court of Appeals for the Third Circuit on Tuesday upheld a lower court's ruling dismissing Eurofins' suit under the doctrine of forum non conveniens and finding that U.S. courts lack jurisdiction over BioAlliance....
To view the full article, register now.